Results 61 to 70 of about 19,638 (219)
The Clinical Approach and Treatment of Benign and Malignant Parotid Masses
Background: Parotid gland tumors account for 80% of all salivary gland neoplasms, 20% of these are malignant, but in daily clinical practice most parotid masses are operated on before obtaining the final histological diagnosis.
Marwan G Saied
doaj +1 more source
Neuroendocrine Carcinoma of the Head and Neck: A Two‐Decade Institutional Experience
ABSTRACT Objectives Primary neuroendocrine carcinoma (NEC) of the head and neck is rare (< 1% of cases) and aggressive, with poorly defined management strategies. This study evaluated clinical characteristics, treatment patterns, and survival outcomes in a single‐institution cohort, identifying factors associated with improved survival.
Micah K. Harris +11 more
wiley +1 more source
ABSTRACT Immune checkpoint inhibitor (ICI)‐driven alterations in the immune system can induce immune‐related adverse events (irAEs). Cutaneous irAEs are notable for being the most common and for their early onset; however, the risk factors underlying their development and severity remain unclear. In this study, we retrospectively analyzed 1224 Japanese
Tomoya Watanabe +4 more
wiley +1 more source
Tumors originating in the parapharyngeal space are rare comprising fewer than 1 % of all head and neck neoplasms. Pleomorphic adenoma is the most common salivary gland neoplasm.
Revant Chole +4 more
doaj
Parotid Gland Mass as the Presenting Symptom of Nasopharyngeal Carcinoma
Even though metastatic tumors of the parotid gland are rarely seen, they are observed more frequently than other salivary gland metastatic masses. The reason why this gland is more frequently affected by metastatic tumors as compared to other salivary ...
Ayşegül Verim +4 more
doaj +1 more source
ABSTRACT Background Facial nerve dysfunction (FND) remains a key complication of parotidectomy. Intraoperative facial nerve monitoring (IOFNM) aims to assist facial nerve identification and preservation; however, its effect on postoperative FND remains unclear.
H. Buntain +5 more
wiley +1 more source
Efficacy of the Systemic Immune Inflammation Index in Malignant and Benign Parotid Neoplasms. [PDF]
Sahin A +4 more
europepmc +1 more source
Treatment of parotid neoplasms.
Over a 25-year period 124 patients were admitted to St. Joseph's Hospital, Toronto with parotid neoplasms; 102 had benign and 22 had malignant lesions. Of 75 pleomorphic adenomas, 26 were enucleated and 11 of them (42%) recurred; no instances of recurrence followed parotidectomy.
R J, Dykun +3 more
openaire +1 more source
ABSTRACT Squamoid Eccrine Ductal Carcinoma (SEDC) is a rare cutaneous adenexal carcinoma first described in 1997. It has distinct biphasic features on histology which commonly result in misdiagnosis as Bowen disease or cutaneous squamous cell carcinomas (cSCC) if diagnostic skin biopsies are too superficial. This may lead to a delay in diagnosis. It is
Xiang Li Tan +15 more
wiley +1 more source
This retrospective study reviews 111 salivary gland fine‐needle aspiration cytology (FNAC) cases collected over an 11‐year period and reclassifies them according to the Milan System for Reporting Salivary Gland Cytopathology. Cytology‐histopathology correlation was performed for excision specimens, confirming the system's accuracy in distinguishing non‐
Shifa F. Khan +4 more
wiley +1 more source

